Sarepta Therapeutics (SRPT) Gains from Investment Securities (2012 - 2014)

Sarepta Therapeutics' Gains from Investment Securities history runs 3 years deep, the most recent figure standing at -$4.3 million for Q3 2014.

• On a quarterly basis, Gains from Investment Securities fell 124.8% year-over-year to -$4.3 million in Q3 2014; TTM through Dec 2014 was $2.8 million, a 87.38% decrease from a year earlier, with the FY2014 full-year figure at $2.8 million, down 87.38% from the prior year.
• Gains from Investment Securities fell to -$4.3 million in Q3 2014 per SRPT's latest filing, from $3.8 million in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $51.8 million in Q4 2012 and bottomed at -$24.0 million in Q4 2013.
• The 3-year median for Gains from Investment Securities is $3.8 million (2014), against an average of $10.6 million.
• Biggest YoY gain for Gains from Investment Securities was 146.26% in 2013; the steepest drop was 146.32% in 2013.
• Year by year, Gains from Investment Securities stood at $51.8 million in 2012, then tumbled by 146.32% to -$24.0 million in 2013, then jumped by 82.25% to -$4.3 million in 2014.
• Per Business Quant, the three latest SRPT Gains from Investment Securities figures stand at -$4.3 million (Q3 2014), $3.8 million (Q2 2014), and $3.3 million (Q1 2014).